Travere Therapeutics Inc —— 资产负债表 (NASDAQ:TVTX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 607.44 M776.63 M672.59 M788.91 M594.13 M605.19 M 负债总额 396.23 M474.52 M629.73 M588.1 M535.05 M490.36 M 权益总额 211.21 M302.11 M42.85 M200.81 M59.08 M114.83 M 负债及股东权益总额 607.44 M776.63 M672.59 M788.91 M594.13 M605.19 M 总债务 215.34 M226.58 M375.55 M377.26 M378.99 M311.72 M 净债务 -141.23 M-201.36 M28.33 M70.45 M320.45 M73.31 M

新闻

Travere Therapeutics: Re-Rating Potential As Filspari Wins Full Approval (NASDAQ:TVTX)

TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication

Travere (TVTX) Soars 37.2%: Is Further Upside Left in the Stock?

Stocks Rally on a Push for Diplomacy to End US-Iran War

Stocks Rally on US-Iran Peace Hopes and Cooler PPI Growth

Stocks Climb on US-Iran Peace Talk Optimism and a Favorable PPI Report

Travere Therapeutics Stock Skyrockets On Highly Anticipated FDA Approval

Travere Therapeutics, Inc. (TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS Transcript

Travere Therapeutics, Inc. (TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS - Slideshow (NASDAQ:TVTX) 2026-04-13

Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists

ASML, An AI Megatrend Star, Leads 8 Newcomers To Best Stock Lists

Two Biotech Stocks Hover Near Highs; Natural Gas And Finance Names Show Resilience